We are live on
!
Find out more
DnB Asset Management Portfolio holdings
AUM
$28B
1-Year Est. Return
26%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$21.7B
AUM Growth
-$1.42B
(-6.1%)
Cap. Flow
+$74.1M
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
37.96%
Holding
778
New
46
Increased
318
Reduced
356
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$323M |
| 2 |
Oracle
ORCL
|
+$303M |
| 3 |
SNDK
Sandisk
SNDK
|
+$244M |
| 4 |
Marvell Technology
MRVL
|
+$180M |
| 5 |
Booking.com
BKNG
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$355M |
| 2 |
Mastercard
MA
|
+$247M |
| 3 |
Electronic Arts
EA
|
+$222M |
| 4 |
Western Digital
WDC
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.89% |
| 2 | Communication Services | 13.62% |
| 3 | Financials | 12.74% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Healthcare | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Comfort Systems
FIX
$53.5B
| $380K | ﹤0.01% |
+1,179
| New | +$476K |
|
677
Real Brokerage
REAX
$360M
| $377K | ﹤0.01% |
+92,761
| New | +$440K |
|
678
Vaxcyte
PCVX
$7.65B
| $371K | ﹤0.01% |
9,831
+2,764
| +39% | +$221K |
|
679
NIO
NIO
$11.9B
| $354K | ﹤0.01% |
92,984
-1,100
| -1% | -$4.84K |
|
680
Kanzhun
BZ
$7.19B
| $336K | ﹤0.01% |
17,544
| – | – |
|
681
Alkermes
ALKS
$8.11B
| $328K | ﹤0.01% |
9,928
-3,248
| -25% | -$106K |
|
682
CleanSpark
CLSK
$3.08B
| $326K | ﹤0.01% |
+48,492
| New | +$459K |
|
683
Immunocore
IMCR
$1.7B
| $322K | ﹤0.01% |
10,853
+555
| +5% | +$16.6K |
|
684
Krystal Biotech
KRYS
$10.7B
| $321K | ﹤0.01% |
1,779
+242
| +16% | +$40.7K |
|
685
XPO
XPO
$23.4B
| $319K | ﹤0.01% |
+2,968
| New | +$377K |
|
686
Ambarella
AMBA
$3.04B
| $315K | ﹤0.01% |
+6,259
| New | +$428K |
|
687
Iovance Biotherapeutics
IOVA
$2.04B
| $305K | ﹤0.01% |
91,580
+50,802
| +125% | +$262K |
|
688
NuScale Power
SMR
$2.63B
| $293K | ﹤0.01% |
+20,659
| New | +$418K |
|
|
FOLD
689
DELISTED
Amicus Therapeutics
FOLD
| $290K | ﹤0.01% |
35,519
+3,077
| +9% | +$28.5K |
|
690
Anavex Life Sciences
AVXL
$231M
| $285K | ﹤0.01% |
+33,261
| New | +$314K |
|
691
Iris Energy
IREN
$10.5B
| $285K | ﹤0.01% |
+46,855
| New | +$456K |
|
692
TG Therapeutics
TGTX
$8.19B
| $281K | ﹤0.01% |
+7,121
| New | +$240K |
|
693
Syndax Pharmaceuticals
SNDX
$1.7B
| $275K | ﹤0.01% |
22,378
-565
| -2% | -$7.97K |
|
694
uniQure
QURE
$2.75B
| $268K | ﹤0.01% |
25,320
+3,292
| +15% | +$46.2K |
|
695
Centrus Energy
LEU
$3.14B
| $268K | ﹤0.01% |
+4,312
| New | +$363K |
|
696
Butterfly Network
BFLY
$1.86B
| $262K | ﹤0.01% |
+114,966
| New | +$411K |
|
697
Leidos
LDOS
$14.4B
| $260K | ﹤0.01% |
+1,926
| New | +$269K |
|
698
Acadia Pharmaceuticals
ACAD
$4.51B
| $259K | ﹤0.01% |
15,611
+1,409
| +10% | +$25.6K |
|
699
Crinetics Pharmaceuticals
CRNX
$8.88B
| $249K | ﹤0.01% |
+7,431
| New | +$278K |
|
700
Immunovant
IMVT
$7.93B
| $245K | ﹤0.01% |
14,356
+3,935
| +38% | +$82.3K |
|
Similar funds
N
PCH
TWC
FDCDDQ
NA
DnB Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, DnB Asset Management held 778 positions worth $21.7B, down 6.1% from $23.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
DnB Asset Management's Q1 2025 filing shows 46 new, 318 increased, 356 reduced and 40 closed positions. Its largest new stake was Sandisk: 4,906,280 shares worth $234M. The largest sale was Visa, an estimated $355M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Communication Services and Financials.
- DnB Asset Management's largest Q1 2025 buy was Sandisk: 4,906,280 shares worth $234M.
- DnB Asset Management added most to NVIDIA in Q1 2025, an estimated $323M increase.
- DnB Asset Management's biggest Q1 2025 reduction was Visa, cutting an estimated $355M.
- DnB Asset Management fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $7.31M.
- DnB Asset Management's ten largest holdings make up 38% of its $21.7B portfolio in Q1 2025.
- DnB Asset Management opened 46 new positions and closed 40 in Q1 2025.
- DnB Asset Management's portfolio value fell 6.1% quarter-over-quarter to $21.7B.
Based on DnB Asset Management's 13F filing for Q1 2025, filed 15 May 2025.